HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Experience in 3,500 patients with urinary stones treated with the Dornier HM-4 bath-free lithotriptor.

Abstract
During a 3-year period, hundreds of patients underwent ESWL treatment with the Dornier HM-3 and HM-4 lithotriptors operating at our institution. Our experience in 3,500 patients treated with the HM-4 bath-free lithotriptor is reported. Patients with radiolucent or cystine stones, stones larger than 3 cm or staghorn calculi, multiple stones with a total burden of more than 3 cm and those not amenable to follow-up were excluded from the study. The overall stone-free rate was 70.7% and 81% at 1 and 3 months, respectively. The stone-free rates at 1 and 3 months were further determined by the exact location of each stone within the urinary tract. Stone-free rates at 3 months ranged from 90.84% for renal pelvic stones to 71.08% for lower calyceal stones, while the stone-free rates for ureteral calculi ranged from 80.85% for upper third unstented ureteral stones to 92.92% for lower ureteral stones. The overall complication rate was 6.02% with a 1.2% post-ESWL intervention rate (ureteroscopy or placement of percutaneous nephrostomy or stent).
AuthorsA Kostakopoulos, N I Stavropoulos, G Louras, C Deliveliotis, C Dimopoulos
JournalInternational urology and nephrology (Int Urol Nephrol) Vol. 29 Issue 2 Pg. 147-53 ( 1997) ISSN: 0301-1623 [Print] Netherlands
PMID9241540 (Publication Type: Journal Article)
Topics
  • Disease-Free Survival
  • Follow-Up Studies
  • Humans
  • Lithotripsy (adverse effects, instrumentation, methods)
  • Retrospective Studies
  • Safety
  • Treatment Outcome
  • Urinary Calculi (diagnosis, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: